Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05064722 · ClinicalTrials.gov registry record · NA

Duodenal-Ileal Diversion in Obese Patients Undergoing Primary Sleeve or Those With Inadequate Weight Loss After Sleeve

A NA study, sponsored by GI Windows.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT05064722: Completed NA study, sponsored by GI Windows.

NCT05064722 is a NA study that has completed, run by GI Windows. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05064722, a NA study, has completed, sponsored by GI Windows.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

The objectives of this study are to assess the initial safety and device functionality of the SFM Anastomosis System including delivery systems when used to create a dual-path duodenal-ileal (D-I) diversion either during sleeve gastrectomy (i.e., SNAP-S procedure) or patients with prior sleeve gastrectomy who experience inadequate weight loss (i.e., SNAP-PS procedure). Additionally, the study is designed to evaluate the potential of the SNAP-S/SNAP-PS procedures to induce weight loss and to improve metabolic comorbidities in obese subjects.

Primary Outcome

Total Body Weight Loss from baseline

Interventions

  • DEVICE Self Forming Magnets (SFM)

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2021-11-08
Est. Completion 2024-10-09
Phase NA
GI Windows

4 total trials

What the finished NCT05064722 record still lists

NCT05064722 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Self Forming Magnets (SFM) is the first listed.

NCT05064722 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05064722 about?

NCT05064722 is a clinical study titled "Duodenal-Ileal Diversion in Obese Patients Undergoing Primary Sleeve or Those With Inadequate Weight Loss After Sleeve". The objectives of this study are to assess the initial safety and device functionality of the SFM Anastomosis System including delivery systems when used to create a dual-path duodenal-ileal (D-I) diversion either during sleeve gastrectomy (i.e., SNAP-S procedure) or patients with prior sleeve gastr...

What is the current status of trial NCT05064722?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2021-11-08. Estimated completion is 2024-10-09.

What interventions are being tested in trial NCT05064722?

The interventions under investigation include: Self Forming Magnets (SFM) (DEVICE).

Who is sponsoring clinical trial NCT05064722?

This trial is sponsored by GI Windows, which has 4 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05064722's enrollment target sits among peer trials

10 1927th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05064722, the US trial registry maintained by the National Library of Medicine. NCT05064722 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.